TINF2
Overview of the TINF2 gene and its role in human biology
TINF2[edit]
TINF2 (TERF1-interacting nuclear factor 2) is a gene that encodes a protein involved in the maintenance of telomeres, which are the protective caps at the ends of chromosomes. The TINF2 protein is a critical component of the shelterin complex, a multi-protein structure that protects telomeres from being recognized as sites of DNA damage and regulates telomere length.
Function[edit]
The TINF2 protein interacts with other components of the shelterin complex, including TERF1 (telomeric repeat-binding factor 1) and TERF2 (telomeric repeat-binding factor 2). This interaction is essential for the stabilization of telomeres and the prevention of inappropriate DNA repair activities that could lead to chromosomal end-to-end fusions.
TINF2 plays a crucial role in:
- Maintaining telomere integrity and length.
- Protecting chromosome ends from degradation.
- Regulating the access of telomerase, the enzyme responsible for adding telomeric repeats to the ends of chromosomes.
Clinical Significance[edit]
Mutations in the TINF2 gene have been associated with several human diseases, particularly those related to telomere dysfunction. These include:
- Dyskeratosis congenita, a rare genetic disorder characterized by skin abnormalities, nail dystrophy, and bone marrow failure.
- Revesz syndrome, a severe variant of dyskeratosis congenita, which includes bilateral exudative retinopathy.
- Hoyeraal-Hreidarsson syndrome, a severe form of dyskeratosis congenita with additional neurological and immunological symptoms.
Patients with TINF2 mutations often exhibit very short telomeres, leading to premature cellular senescence and increased susceptibility to age-related diseases.
Research and Developments[edit]
Ongoing research is focused on understanding the precise molecular mechanisms by which TINF2 mutations lead to telomere dysfunction and associated diseases. Studies are also exploring potential therapeutic strategies to correct or compensate for the effects of TINF2 mutations, such as telomerase activation or gene therapy.
Also see[edit]
Template:Human chromosome 14 genes
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
